How psychedelics could deliver antidepressant benefits without hallucinogenic effects
Could psychedelics become a new generation of treatments for depression and other psychiatric disorders? This question is no longer confined to basic research. Several therapies based on classical psychedelics have advanced into late-stage clinical development and have reported encouraging results. DT120, an LSD-based candidate, and COMP360, a synthetic psilocybin formulation, have both received…
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.
